Texas Yale Capital Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Hold |
10,247
| – | – | 0.1% | 128 |
|
|
2025
Q4 | $3.35M | Hold |
10,247
| – | – | 0.1% | 138 |
|
|
2025
Q3 | $2.89M | Buy |
10,247
+50
| +0.5% | +$14.5K | 0.09% | 157 |
|
|
2025
Q2 | $2.85M | Hold |
10,197
| – | – | 0.09% | 152 |
|
|
2025
Q1 | $3.18M | Buy |
10,197
+25
| +0.2% | +$7.38K | 0.13% | 135 |
|
|
2024
Q4 | $2.65M | Hold |
10,172
| – | – | 0.11% | 152 |
|
|
2024
Q3 | $3.28M | Hold |
10,172
| – | – | 0.14% | 126 |
|
|
2024
Q2 | $3.18M | Buy |
10,172
+75
| +0.7% | +$22K | 0.15% | 115 |
|
|
2024
Q1 | $2.87M | Buy |
10,097
+34
| +0.3% | +$9.95K | 0.13% | 131 |
|
|
2023
Q4 | $2.9M | Hold |
10,063
| – | – | 0.14% | 121 |
|
|
2023
Q3 | $2.7M | Hold |
10,063
| – | – | 0.12% | 116 |
|
|
2023
Q2 | $2.23M | Hold |
10,063
| – | – | 0.11% | 146 |
|
|
2023
Q1 | $2.43M | Hold |
10,063
| – | – | 0.12% | 135 |
|
|
2022
Q4 | $2.64M | Buy |
10,063
+1,775
| +21% | +$476K | 0.15% | 120 |
|
|
2022
Q3 | $1.87M | Hold |
8,288
| – | – | 0.12% | 152 |
|
|
2022
Q2 | $2.02M | Hold |
8,288
| – | – | 0.13% | 152 |
|
|
2022
Q1 | $2M | Hold |
8,288
| – | – | 0.11% | 170 |
|
|
2021
Q4 | $1.86M | Hold |
8,288
| – | – | 0.09% | 180 |
|
|
2021
Q3 | $1.76M | Buy |
8,288
+200
| +2% | +$46K | 0.1% | 181 |
|
|
2021
Q2 | $1.97M | Hold |
8,088
| – | – | 0.11% | 165 |
|
|
2021
Q1 | $2.01M | Sell |
8,088
-313
| -4% | -$74.7K | 0.13% | 150 |
|
|
2020
Q4 | $1.93M | Hold |
8,401
| – | – | 0.13% | 152 |
|
|
2020
Q3 | $2.13M | Hold |
8,401
| – | – | 0.16% | 124 |
|
|
2020
Q2 | $1.98M | Hold |
8,401
| – | – | 0.16% | 130 |
|
|
2020
Q1 | $1.7M | Hold |
8,401
| – | – | 0.17% | 125 |
|
|
2019
Q4 | $2.02M | Hold |
8,401
| – | – | 0.14% | 144 |
|
|
2019
Q3 | $1.63M | Hold |
8,401
| – | – | 0.12% | 165 |
|
|
2019
Q2 | $1.55M | Sell |
8,401
-8,401
| -50% | -$1.5M | 0.12% | 176 |
|
|
2019
Q1 | $3.19M | Buy |
16,802
+8,401
| +100% | +$1.6M | 0.13% | 162 |
|
|
2018
Q4 | $1.64M | Hold |
8,401
| – | – | 0.15% | 133 |
|
|
2018
Q3 | $1.74M | Hold |
8,401
| – | – | 0.14% | 143 |
|
|
2018
Q2 | $1.55M | Hold |
8,401
| – | – | 0.13% | 152 |
|
|
2018
Q1 | $1.43M | Hold |
8,401
| – | – | 0.12% | 165 |
|
|
2017
Q4 | $1.46M | Hold |
8,401
| – | – | 0.13% | 158 |
|
|
2017
Q3 | $1.57M | Hold |
8,401
| – | – | 0.14% | 145 |
|
|
2017
Q2 | $1.45M | Hold |
8,401
| – | – | 0.13% | 148 |
|
|
2017
Q1 | $1.38M | Hold |
8,401
| – | – | 0.12% | 152 |
|
|
2016
Q4 | $1.23M | Hold |
8,401
| – | – | 0.12% | 158 |
|
|
2016
Q3 | $1.4M | Hold |
8,401
| – | – | 0.13% | 135 |
|
|
2016
Q2 | $1.28M | Hold |
8,401
| – | – | 0.13% | 150 |
|
|
2016
Q1 | $1.26M | Hold |
8,401
| – | – | 0.13% | 142 |
|
|
2015
Q4 | $1.36M | Hold |
8,401
| – | – | 0.13% | 129 |
|
|
2015
Q3 | $1.16M | Hold |
8,401
| – | – | 0.11% | 161 |
|
|
2015
Q2 | $1.29M | Hold |
8,401
| – | – | 0.11% | 157 |
|
|
2015
Q1 | $1.34M | Hold |
8,401
| – | – | 0.11% | 156 |
|
|
2014
Q4 | $1.34M | Buy |
8,401
+2,631
| +46% | +$410K | 0.12% | 137 |
|
|
2014
Q3 | $810K | Buy |
5,770
+1,535
| +36% | +$200K | 0.08% | 197 |
|
|
2014
Q2 | $501K | Hold |
4,235
| – | – | 0.06% | 255 |
|
|
2014
Q1 | $522K | Buy |
+4,235
| New | +$514K | 0.07% | 227 |
|
Other funds holding AMGN
VCM
VPM
Texas Yale Capital Corp's AMGN Position: Q1 2026 in Review
Texas Yale Capital Corp held its Amgen (AMGN) position steady in Q1 2026 at 10,247 shares worth $3.61M. The position accounts for 0.1% of the portfolio, ranked #128.
Texas Yale Capital Corp first reported a position in AMGN in Q1 2014 and has held it in 49 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Texas Yale Capital Corp held 10,247 shares of Amgen worth $3.61M as of Q1 2026.
- Texas Yale Capital Corp left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.1% of Texas Yale Capital Corp's portfolio in Q1 2026, its #128 holding.
- Texas Yale Capital Corp first reported a position in Amgen in Q1 2014 and has held it in 49 quarters since.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Texas Yale Capital Corp's 13F filing for Q1 2026, filed 4 May 2026.